N E W S 

PRESS RELEASE, 18 February 2020

Neuroplast raises € 4 million for its stem cell-based technology to treat patients with Spinal Cord Injury. 

Read more

​

​

PRESS RELEASE, 01 May 2019

European Medicines Agency (EMA) has granted Orphan Drug Designation to Neuroplast treatment. 

Read more

​

​

​